Register Now REGISTER NOW for the Medscape Education and IASLC Exclusive Webinar: Immunotherapy and the COVID-19 Pandemic: Addressing Clinical Case Challenges in Lung Cancer on Tuesday, August 11, 2020 @ […] Read more
Dr. Harpreet Singh Discusses the Conduct of FDA Clinical Trials During the COVID-19 Pandemic
Harpreet Singh, MD, is director of Division of Oncology 2 at the U.S. Food and Drug Administration (FDA). In the following interview, she discusses the FDA’s response to the COVID-19 […] Read more
By José Francisco Corona-Cruz, MD We are living in an uncertain world in which the impact, timeline, and duration of the COVID-19 pandemic remain mostly unknown. This has led to […] Read more
By Joy Curzio Since the start of the COVID-19, it has been established that patients with cancer are more severely impacted by the virus than healthy individuals or than […] Read more
The referenced media source is missing and needs to be re-embedded. Read more
Broad Molecular Testing in Lung Cancer: The Struggle to Translate Recommendations to Clinical Practice
By Kara Nyberg, PhD Posted: June 24, 2020 Over the past decade, lung cancer has emerged as a shining example of how precision medicine can dramatically improve patient outcomes. Up […] Read more
By Kara Nyberg, PhD Posted: June 24, 2020 New findings from the TRACERx lung study underscore the value of using circulating tumor DNA (ctDNA) to predict NSCLC relapse postsurgery based […] Read more
Evolution of Research Using Patient-Reported Outcomes in Lung Cancer: A Q&A With Dr. Benjamin Movsas
Posted: June 24, 2020 The IASLC Lung Cancer News spoke with Benjamin Movsas, MD, regarding the evolution of patient-reported outcomes (PROs) for lung cancer. Dr. Movsas is the co-chair of […] Read more
By Tetsuya Mitsudomi, MD Posted: April 16, 2020 The general principle of surgery for cancer of any organ is to remove the entire tumor with adequate margins of normal tissue […] Read more